Roger Clair Duvoisin - Publications

Affiliations: 
New York Medical College, New York, NY, United States 

166 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Anderson LL, Vilensky JA, Duvoisin RC. Review: neuropathology of acute phase encephalitis lethargica: a review of cases from the epidemic period. Neuropathology and Applied Neurobiology. 35: 462-72. PMID 19490429 DOI: 10.1111/j.1365-2990.2009.01024.x  1
1999 Golbe LI, Di Iorio G, Lazzarini A, Vieregge P, Gershanik OS, Bonavita V, Duvoisin RC. The Contursi kindred, a large family with autosomal dominant Parkinson's disease: implications of clinical and molecular studies. Advances in Neurology. 80: 165-70. PMID 10410717  1
1999 Duvoisin RC. Genetic and environmental factors in Parkinson's disease. Advances in Neurology. 80: 161-3. PMID 10410716  1
1998 Duvoisin RC. Role of genetics in the cause of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 7-12. PMID 9613712  1
1998 Duvoisin RC, Atwood GW, Hallum B, Mace NL, Rabins PV, Pitzele SK, Wilson JR, McGoon DC. Management of Parkinson's disease Neurology. 50: S2-S57.  1
1997 Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, ... ... Duvoisin RC, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (New York, N.Y.). 276: 2045-7. PMID 9197268 DOI: 10.1126/science.276.5321.2045  1
1996 Golbe LI, Di Iorio G, Sanges G, Lazzarini AM, La Sala S, Bonavita V, Duvoisin RC. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Annals of Neurology. 40: 767-75. PMID 8957018 DOI: 10.1002/ana.410400513  1
1996 Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G, Sanges G, Stenroos ES, Pho LT, Schaffer AA, Lazzarini AM, Nussbaum RL, Duvoisin RC. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science (New York, N.Y.). 274: 1197-9. PMID 8895469 DOI: 10.1126/science.274.5290.1197  1
1996 Golbe LI, Rubin RS, Cody RP, Belsh JM, Duvoisin RC, Grosmann C, Lepore FE, Mark MH, Sachdeo RC, Sage JI, Zimmerman TR. Follow-up study of risk factors in progressive supranuclear palsy. Neurology. 47: 148-54. PMID 8710069  1
1996 Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 47: 1-9. PMID 8710059 DOI: 10.1212/WNL.47.1.1  1
1996 Duvoisin RC. Recent advances in the genetics of Parkinson's disease. Advances in Neurology. 69: 33-40. PMID 8615148  1
1996 Mark MH, Dickson DW, Sage JI, Duvoisin RC. The clinicopathologic spectrum of Lewy body disease. Advances in Neurology. 69: 315-8. PMID 8615145  1
1995 Mizuno Y, Kondo T, Narabayashi H, Mori H, Calne DB, Teychenne PF, Claveria LE, Lang AE, Quinn N, Drincat S, Lieberman A, Goldstein M, Leibowitz M, Gopinathan G, Teravainen H, ... ... Duvoisin RC, et al. Pergolide in the treatment of parkinson's disease Neurology. 45: S13-S21. PMID 7715792  1
1995 Mark MH, Sage JI, Walters AS, Duvoisin RC, Miller DC. Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 450-4. PMID 7565825 DOI: 10.1002/mds.870100408  1
1994 Lazzarini AM, Myers RH, Zimmerman TR, Mark MH, Golbe LI, Sage JI, Johnson WG, Duvoisin RC. A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology. 44: 499-506. PMID 8145922 DOI: 10.1212/WNL.44.3_Part_1.499  1
1994 Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Stern M, Shoulson I, Kurlan R, Grimes JD, Jankovic J. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 40-7. PMID 8139604 DOI: 10.1002/mds.870090107  1
1994 Calne DB, Duvoisin RC, Koller WC. Individualizing therapy in patients with disabling Parkinson's disease symptoms. Neurology. 44: S8-11. PMID 8121579  1
1994 Mark MH, Sage JI, Dickson DW, Heikkila RE, Manzino L, Schwarz KO, Duvoisin RC. Meige syndrome in the spectrum of Lewy body disease. Neurology. 44: 1432-6. PMID 8058144  1
1994 Duvoisin RC. Differential diagnosis of PSP. Journal of Neural Transmission. Supplementum. 42: 51-67. PMID 7964697  1
1994 Tolosa E, Duvoisin R, Cruz-Sanchez FF. Progressive supranuclear palsy: Preface Journal of Neural Transmission, Supplement. VII-VIII.  1
1993 Duvoisin RC. The genetics of Parkinson's disease. A review. Advances in Neurology. 60: 306-15. PMID 8420146  1
1993 Golbe LI, Lazzarini AM, Schwarz KO, Mark MH, Dickson DW, Duvoisin RC. Autosomal dominant parkinsonism with benign course and typical Lewy-body pathology. Neurology. 43: 2222-7. PMID 8232933  1
1992 Duvoisin RC. Overview of Parkinson's disease. Annals of the New York Academy of Sciences. 648: 187-93. PMID 1637046  1
1992 Mark MH, Sage JI, Dickson DW, Schwarz KO, Duvoisin RC. Levodopa-nonresponsive Lewy body parkinsonism: clinicopathologic study of two cases. Neurology. 42: 1323-7. PMID 1620341  1
1992 Duvoisin RC. A brief history of parkinsonism. Neurologic Clinics. 10: 301-16. PMID 1584174  1
1992 Lazzarini A, Zimmerman TR, Johnson WG, Duvoisin RC. A 17th-century founder gives rise to a large north American pedigree of autosomal dominant spinocerebellar ataxia not linked to the SCA1 locus on chromosome 6. Neurology. 42: 2118-24. PMID 1436521  1
1992 Burn DJ, Mark MH, Playford ED, Maraganore DM, Zimmerman TR, Duvoisin RC, Harding AE, Marsden CD, Brooks DJ. Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology. 42: 1894-900. PMID 1407569  1
1992 Duvoisin RC, Johnson WG. Hereditary Lewy-body parkinsonism and evidence for a genetic etiology of Parkinson's disease. Brain Pathology (Zurich, Switzerland). 2: 309-20. PMID 1341965  1
1992 Duvoisin RC. The genetic etiology of Parkinson's disease. A review of the evidence Neurologia. 7: 223-229.  1
1991 Duvoisin RC. Spasmodic torticollis: the role of surgical denervation. Mayo Clinic Proceedings. 66: 433-5. PMID 2013994  1
1991 Lauterbach EC, Duvoisin RC. Anxiety disorders in familial parkinsonism. The American Journal of Psychiatry. 148: 274. PMID 1987832  1
1990 Johnson WG, Hodge SE, Duvoisin R. Twin studies and the genetics of Parkinson's disease - a reappraisal Movement Disorders. 5: 187-194. PMID 2388635 DOI: 10.1002/MDS.870050302  1
1990 McHale DM, Sage JI, Sonsalla PK, Heikkila RE, Duvoisin RC. Steady plasma levodopa concentrations required for good clinical response to CR-4 in patients with 'on-off'. European Neurology. 30: 90-2. PMID 2340841 DOI: 10.1159/000117318  0.6
1990 Menza MA, Sage J, Marshall E, Cody R, Duvoisin R. Mood changes and 'on-off' phenomena in Parkinson's disease Movement Disorders. 5: 148-151. PMID 2325676 DOI: 10.1002/mds.870050210  1
1990 Golbe LI, Miller DC, Duvoisin RC. Autosomal dominant Lewy-body Parkinson's disease. Advances in Neurology. 53: 287-92. PMID 2173372  1
1990 Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC. A large kindred with autosomal dominant Parkinson's disease. Annals of Neurology. 27: 276-82. PMID 2158268 DOI: 10.1002/ana.410270309  1
1990 Sage JI, Sonsalla PK, McHale DM, Heikkila RE, Duvoisin RC. Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease. Advances in Neurology. 53: 383-6. PMID 2122646  1
1990 Chokroverty S, Nicklas W, Miller DC, Goldberg J, Choe J, Banner C, Thomas J, Duvoisin R. Multiple system degeneration with glutamate dehydrogenase deficiency: Pathology and biochemistry Journal of Neurology, Neurosurgery and Psychiatry. 53: 1099-1101. PMID 1705575 DOI: 10.1136/jnnp.53.12.1099  1
1990 Sage JI, Miller DC, Golbe LI, Walters A, Duvoisin RC. Clinically atypical expression of pathologically typical Lewy-body parkinsonism. Clinical Neuropharmacology. 13: 36-47. PMID 1689615  1
1989 Nygaard TG, Duvoisin RC, Manocha M, Chokroverty S. Seizures in progressive supranuclear palsy. Neurology. 39: 138-40. PMID 2909902  1
1989 Chokroverty S, Sachdeo R, Dilullo J, Duvoisin RC. Magnetic stimulation in the diagnosis of lumbosacral radiculopathy. Journal of Neurology, Neurosurgery, and Psychiatry. 52: 767-72. PMID 2746269  1
1989 Duvoisin RC, Golbe LI. Toward a definition of Parkinson's disease. Neurology. 39: 746. PMID 2710369  1
1989 Duvoisin RC. New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation. Neurology. 39: 4-6. PMID 2573862  1
1989 Walters AS, Hening W, Chokroverty S, Duvoisin R. Restlessness of the arms as the principal manifestation of neuroleptic-induced akathisia. Journal of Neurology. 236: 435. PMID 2572683 DOI: 10.1007/BF00314908  1
1989 Golbe LI, Miller DC, Duvoisin RC. Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 147-52. PMID 2543919 DOI: 10.1002/mds.870040206  1
1989 Duvoisin RC. New strategies in controlled-release formulation: Closing remarks Neurology. 39: 106.  1
1989 Sage JI, Duvoisin RC. The Parkinson plus syndromes Current Opinion in Neurology and Neurosurgery. 2: 314-318.  1
1988 Davis PH, Golbe LI, Duvoisin RC, Schoenberg BS. Risk factors for progressive supranuclear palsy. Neurology. 38: 1546-52. PMID 3419596  1
1988 Sage JI, Trooskin S, Sonsalla PK, Heikkila R, Duvoisin RC. Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonism. Annals of Neurology. 24: 87-9. PMID 3415201 DOI: 10.1002/ana.410240116  1
1988 Sage JI, Trooskin S, Schuh L, Duncsak P, Sonsalla PK, Heikkila RE, Manzino L, Reddell M, Duvoisin RC. Isolated jejunal pouches for levodopa delivery in parkinsonian patients with "on-off". Successful experimental model in dogs. Clinical Neuropharmacology. 11: 212-20. PMID 3401857  1
1988 Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology. 38: 1031-4. PMID 3386818  1
1988 Sage JI, Schuh L, Heikkila RE, Duvoisin RC. Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease. Clinical Neuropharmacology. 11: 36-44. PMID 3349496  1
1988 Duvoisin RC, Nicklas WJ, Ritchie V, Sage J, Chokroverty S. Low leukocyte glutamate dehydrogenase activity does not correlate with a particular type of multiple system atrophy. Journal of Neurology, Neurosurgery, and Psychiatry. 51: 1508-11. PMID 3221218 DOI: 10.1136/jnnp.51.12.1508  1
1988 Lepore FE, Steele JC, Cox TA, Tillson G, Calne DB, Duvoisin RC, Lavine L, McDarby JV. Supranuclear disturbances of ocular motility in Lytico-Bodig. Neurology. 38: 1849-53. PMID 3194062  1
1988 Kindt MV, Youngster SK, Sonsalla PK, Duvoisin RC, Heikkila RE. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP. European Journal of Pharmacology. 146: 313-8. PMID 3131149 DOI: 10.1016/0014-2999(88)90308-1  1
1988 Golbe LI, Lieberman AN, Muenter MD, Ahlskog JE, Gopinathan G, Neophytides AN, Foo SH, Duvoisin RC. Deprenyl in the treatment of symptom fluctuations in advanced Parkinson's disease. Clinical Neuropharmacology. 11: 45-55. PMID 3127050  1
1988 Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Advances in Neurology. 50: 377-84. PMID 3041760  1
1987 Duvoisin RC. Genetics of Parkinson's disease. Advances in Neurology. 45: 307-12. PMID 3825703  1
1987 Duvoisin RC. To treat early or to treat late? Annals of Neurology. 22: 2-3. PMID 3631917 DOI: 10.1002/ana.410220103  1
1987 Golbe LI, Bernholc AA, Duvoisin RC. Smoking, cancer, and Parkinson's disease. Annals of Neurology. 21: 513. PMID 3592644 DOI: 10.1002/ana.410210524  1
1987 Chokroverty S, Manocha MK, Duvoisin RC. A physiologic and pharmacologic study in anticholinergic-responsive essential myoclonus. Neurology. 37: 608-15. PMID 3561772  1
1987 Walters AS, Katchen M, Fleishman J, Chokroverty S, Duvoisin R. Role of the basal ganglia and cerebral cortex in tardive dyskinesia: evidence from cerebrovascular accident Journal of Neurology Neurosurgery and Psychiatry. 50: 367-368. PMID 3559625 DOI: 10.1136/JNNP.50.3.367  1
1987 Schonfeld SM, Golbe LI, Sage JI, Safer JN, Duvoisin RC. Computed tomographic findings in progressive supranuclear palsy: correlation with clinical grade. Movement Disorders : Official Journal of the Movement Disorder Society. 2: 263-78. PMID 3504554 DOI: 10.1002/mds.870020404  1
1987 Duvoisin RC, Golbe LI, Lepore FE. Progressive supranuclear palsy. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 14: 547-54. PMID 3315157  1
1987 Duvoisin R. History of parkinsonism Pharmacology and Therapeutics. 32: 1-17. PMID 3295896 DOI: 10.1016/0163-7258(87)90061-1  1
1987 Golbe LI, Duvoisin RC. Double-blind trial of R-(-)-deprenyl for the "on-off" effect complicating Parkinson's disease. Journal of Neural Transmission. Supplementum. 25: 123-9. PMID 3123598  1
1987 Heikkila RE, Nicklas WJ, Duvoisin RC. Studies on the mechanism of the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Advances in Neurology. 45: 149-52. PMID 3103384  1
1987 Golbe LI, Cody RA, Duvoisin RC. Reply Archives of Neurology. 44: 1111. DOI: 10.1001/archneur.1987.00520230007004  1
1986 Bharucha NE, Stokes L, Schoenberg BS, Ward C, Ince S, Nutt JG, Eldridge R, Calne DB, Mantel N, Duvoisin R. A case-control study of twin pairs discordant for Parkinson's disease: a search for environmental risk factors. Neurology. 36: 284-8. PMID 3945402  1
1986 Nygaard TG, Duvoisin RC. Hereditary dystonia-parkinsonism syndrome of juvenile onset. Neurology. 36: 1424-8. PMID 3762960  1
1986 Golbe LI, Cody RA, Duvoisin RC. Smoking and Parkinson's disease. Search for a dose-response relationship. Archives of Neurology. 43: 774-8. PMID 3729757 DOI: 10.1001/archneur.1986.00520080022014  1
1986 Sage JI, Duvoisin RC. Long-term efficacy of pergolide in patients with Parkinson's disease. Clinical Neuropharmacology. 9: 160-4. PMID 3708601  1
1986 Duvoisin RC. On heredity, twins, and Parkinson's disease. Annals of Neurology. 19: 409-11. PMID 3707097 DOI: 10.1002/ana.410190422  1
1986 Sage JI, Duvoisin RC. Sudden onset of confusion with severe exacerbation of parkinsonism during levodopa therapy. Movement Disorders : Official Journal of the Movement Disorder Society. 1: 267-70. PMID 3504249 DOI: 10.1002/mds.870010406  1
1986 Katchen M, Duvoisin RC. Parkinsonism following dystonia in three patients. Movement Disorders : Official Journal of the Movement Disorder Society. 1: 151-7. PMID 3504239 DOI: 10.1002/mds.870010210  1
1986 Youngster SK, Duvoisin RC, Hess A, Sonsalla PK, Kindt MV, Heikkila RE. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in mice. European Journal of Pharmacology. 122: 283-7. PMID 3486770 DOI: 10.1016/0014-2999(86)90115-9  0.6
1986 Duvoisin RC. Etiology of Parkinson's disease: current concepts. Clinical Neuropharmacology. 9: S3-21. PMID 2423234  1
1986 Lepore FE, Duvoisin RC. ‘Apraxia’ of eye opening in idiopathic parkinson’s disease: Reply from the authors Neurology. 36: 134.  1
1985 Duvoisin RC. Parkinson's disease: intrauterine influence in twins? Neurology. 35: 774-5. PMID 3990979  1
1985 Chokroverty S, Duvoisin RC, Sachdeo R, Sage J, Lepore F, Nicklas W. Neurophysiologic study of olivopontocerebellar atrophy with or without glutamate dehydrogenase deficiency. Neurology. 35: 652-9. PMID 3990965  1
1985 Lepore FE, Duvoisin RC. "Apraxia" of eyelid opening: an involuntary levator inhibition. Neurology. 35: 423-7. PMID 3974904  1
1985 Heikkila RE, Duvoisin RC, Finberg JP, Youdim MB. Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B. European Journal of Pharmacology. 116: 313-7. PMID 3935467 DOI: 10.1016/0014-2999(85)90168-2  1
1985 Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC. Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase B. Journal of Neurochemistry. 45: 1049-54. PMID 3928814  1
1985 Heikkila RE, Hess A, Duvoisin RC. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity. Life Sciences. 36: 231-6. PMID 3917525 DOI: 10.1016/0024-3205(85)90064-5  1
1985 Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Neuroscience Letters. 62: 389-94. PMID 3912685 DOI: 10.1016/0304-3940(85)90580-4  1
1985 Sage JI, Duvoisin RC. Pergolide therapy in Parkinson's disease: a double-blind, placebo-controlled study. Clinical Neuropharmacology. 8: 260-5. PMID 3899352  1
1985 Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in mice. Neuroscience Letters. 58: 133-7. PMID 3876523 DOI: 10.1016/0304-3940(85)90342-8  1
1985 Heikkila RE, Youngster SK, Manzino L, Cabbat FS, Duvoisin RC. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and related compounds on the uptake of [3H]3,4-dihydroxyphenylethylamine and [3H]5-hydroxytryptamine in neostriatal synaptosomal preparations. Journal of Neurochemistry. 44: 310-3. PMID 3871120 DOI: 10.1111/j.1471-4159.1985.tb07146.x  1
1985 Heikkila RE, Nicklas WJ, Duvoisin RC. Dopaminergic toxicity after the stereotaxic administration of the 1-methyl-4-phenylpyridinium ion (MPP+) to rats. Neuroscience Letters. 59: 135-40. PMID 2413402 DOI: 10.1016/0304-3940(85)90227-7  1
1985 Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC. Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) by monoamine oxidase B Federation Proceedings. 44: No. 4908.  1
1984 Duvoisin RC. Essential myoclonus: response to anticholinergic therapy. Clinical Neuropharmacology. 7: 141-7. PMID 6733693  1
1984 Duvoisin RC. Is Parkinson's disease acquired or inherited? The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 11: 151-5. PMID 6713313  1
1984 Calne DB, Duvoisin RC, McGeer E. Speculations on the etiology of Parkinson's disease. Advances in Neurology. 40: 353-60. PMID 6695611  1
1984 Heikkila RE, Cabbat FS, Manzino L, Duvoisin RC. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice. Neuropharmacology. 23: 711-3. PMID 6611514 DOI: 10.1016/0028-3908(84)90170-9  1
1984 Heikkila RE, Hess A, Duvoisin RC. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science (New York, N.Y.). 224: 1451-3. PMID 6610213  1
1984 Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R, Calne DB, Dambrosia J. Parkinson's disease in twins. Advances in Neurology. 40: 341-4. PMID 6538060  1
1984 Duvoisin RC. An apology and an introduction to the olivopontocerebellar atrophies. Advances in Neurology. 41: 5-12. PMID 6496230  1
1984 Duvoisin RC, Chokroverty S. Clinical expression of glutamate dehydrogenase deficiency. Advances in Neurology. 41: 267-79. PMID 6496228  1
1984 Chokroverty S, Khedekar R, Derby B, Sachdeo R, Yook C, Lepore F, Nicklas W, Duvoisin RC. Pathology of olivopontocerebellar atrophy with glutamate dehydrogenase deficiency. Neurology. 34: 1451-5. PMID 6493492  1
1984 Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature. 311: 467-9. PMID 6332989  1
1984 Heikkila RE, Cabbat FS, Manzino L, Duvoisin RC. Studies on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6,-tetrahydropyridine (MPTP) in mice Federation Proceedings. 43: no. 2679.  1
1984 Duvoisin RC, Heikkila RE. Re: Pergolide versus bromocriptine Neurology. 34: 258.  1
1983 Duvoisin RC. Meige syndrome: relief on high-dose anticholinergic therapy. Clinical Neuropharmacology. 6: 63-6. PMID 6850651  1
1983 Gershanik O, Heikkila RE, Duvoisin RC. Effects of dopamine depletion on rotational behavior to dopamine agonists. Brain Research. 261: 358-60. PMID 6831221 DOI: 10.1016/0006-8993(83)90645-5  1
1983 Duvoisin RC, Chokroverty S, Lepore F, Nicklas W. Glutamate dehydrogenase deficiency in patients with olivopontocerebellar atrophy. Neurology. 33: 1322-6. PMID 6684227  1
1983 Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R, Calne DB. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology. 33: 815-24. PMID 6683366  1
1983 Gershanik O, Heikkila RE, Duvoisin RC. Behavioral correlations of dopamine receptor activation. Neurology. 33: 1489-92. PMID 6605497  1
1983 Plaitakis A, Duvoisin RC. Homer's moly identified as Galanthus nivalis L.: physiologic antidote to stramonium poisoning. Clinical Neuropharmacology. 6: 1-5. PMID 6342763  1
1982 Duvoisin RC. Management of patients who fail to respond to levodopa therapy. Clinical Neuropharmacology. 5: S13-8. PMID 7116342  1
1982 Duvoisin RC, Heikkila RE, Manzino L. Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway. Neurology. 32: 1387-91. PMID 6128698  1
1982 Gershanik OS, Heikkila RE, Duvoisin RC, Manzino L. Behavioral correlates of dopamine receptor interaction Neurology. 32: A 161.  1
1981 Barbeau A, Duvoisin RC, Gerstenbrand F, Lakke JP, Marsden CD, Stern G. Classification of extrapyramidal disorders. Proposal for an international classification and glossary of terms. Journal of the Neurological Sciences. 51: 311-27. PMID 7276982 DOI: 10.1016/0022-510X(81)90109-X  1
1981 Heikkila RE, Shapiro BS, Duvoisin RC. The relationship between loss of dopamine nerve terminals, striatal [3H]spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats. Brain Research. 211: 285-92. PMID 7237124 DOI: 10.1016/0006-8993(81)90614-4  1
1981 Duvoisin RC, Eldridge R, Williams A, Nutt J, Calne D. Twin study of Parkinson disease. Neurology. 31: 77-80. PMID 7192828  1
1981 Heikkila RE, Cabbat FS, Manzino L, Duvoisin RC. Potentiation by deprenil of 1-dopa induced circling in nigral-lesioned rats. Pharmacology, Biochemistry, and Behavior. 15: 75-9. PMID 6794038 DOI: 10.1016/0091-3057(81)90342-7  1
1981 Duvoisin RC, Heikkila RE. Pergolide-induced circling in rats with 6-hydroxydopamine lesions of the nigrostriatal pathway Neurology. 31: 133.  1
1980 Duvoisin RC, Mendoza MM, Yahr MD. A comparative study of bromocriptine and levodopa in Parkinson's disease. Advances in Biochemical Psychopharmacology. 23: 271-5. PMID 7395618  1
1980 Duvoisin RC. Neurology. A group of three related articles Postgraduate Medicine. 68: 84-85.  1
1980 Heikkila RE, Shapiro BS, Duvoisin RC. The relationship between the extent of lesioning, 3H-spiroperidol (SP) binding and circling behavior in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the substantia nigra (SN) Federation Proceedings. 39: 3898.  1
1979 Heikkila RE, Cabbat FS, Duvoisin RC. Motor activity and rotational behavior after analogs of cocaine: correlation with dopamine uptake blockade. Communications in Psychopharmacology. 3: 285-90. PMID 575770  1
1979 Heikkila RE, Cabbat FS, Manzino L, Duvoisin RC. Rotational behavior induced by cocaine analogs in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra: dependence upon dopamine uptake inhibition. The Journal of Pharmacology and Experimental Therapeutics. 211: 189-94. PMID 573788  1
1979 Gershanik OS, Heikkila RE, Duvoisin RC. Asymmetric action of intraventricular monoamine neurotoxins. Brain Research. 174: 345-50. PMID 487133 DOI: 10.1016/0006-8993(79)90860-6  1
1979 Nicklas WJ, Duvoisin RC, Berl S. Amino acids in rat neostriatum: alteration by kainic acid lesion. Brain Research. 167: 107-17. PMID 455057 DOI: 10.1016/0006-8993(79)90266-X  1
1979 Heikkila RE, Cabbat FS, Manzino L, Duvoisin RC. Effects of cocaine analogs on rotational behavior and motor activity: Correlation with dopamine (DA) uptake blockade in vitro Federation Proceedings. 38: No.3307.  1
1979 Duvoisin RC, Mytilineou C. Morphologic and behavioral effects of kainic acid injected into rat striatum Canadian Journal of Neurological Sciences. 6: 77.  1
1979 Gershanik OS, Heikkila RE, Duvoisin RC. The role of serotonin neurons in the action of L-dopa in an animal model of parkinsonism Neurology. 29: 553.  1
1978 Duvoisin RC, Mytilineou C. Where is l-DOPA decarboxylated in the striatum after 6-hydroxydopamine nigrotomy? Brain Research. 152: 369-373. PMID 567088 DOI: 10.1016/0006-8993(78)90266-4  1
1978 Duvoisin RC, Heikkila RE, Manzino L. Circling induced by dopamine uptake inhibitors. The Journal of Pharmacy and Pharmacology. 30: 714-6. PMID 31436  1
1977 Duvoisin RC. Problems in the treatment of Parkinsonism Advances in Experimental Medicine and Biology. 90: 131-155. PMID 930741  1
1977 Asnis GM, Leopold MA, Duvoisin RC, Schwartz AH. A survey of tardive dyskinesia in psychiatric outpatients. The American Journal of Psychiatry. 134: 1367-70. PMID 335900  1
1976 Duvoisin RC. Parkinsonism: animal analogues of the human disorder Research Publications - Association For Research in Nervous and Mental Disease. 55: 293-303. PMID 826997  1
1975 Duvoisin RC, Marsden CD. Note on the scoliosis of Parkinsonism Journal of Neurology, Neurosurgery and Psychiatry. 38: 787-793. PMID 1185199 DOI: 10.1136/jnnp.38.8.787  1
1975 Duvoisin RC. Antagonism of Levodopa by Papaverine Jama: the Journal of the American Medical Association. 231: 845. PMID 1172755 DOI: 10.1001/jama.1975.03240200043025  1
1975 Duvoisin RC, Marsden CD. Alpha-methyldopamine as a dopaminergic agonist Advances in Neurology. 9: 243-248. PMID 1146655  1
1975 Marsden CD, Duvoisin RC, Jenner P, Parkes JD, Pycock C, Tarsy D. Relationship between animal models and clinical parkinsonism. Advances in Neurology. 9: 165-75. PMID 1146651  1
1974 Marsden CD, Dolphin A, Duvoisin RC, Jenner P, Tarsy D. Role of noradrenaline in levodopa reversal of reserpine akinesia. Brain Research. 77: 521-5. PMID 4854165 DOI: 10.1016/0006-8993(74)90643-X  1
1974 Duvoisin RC, Marsden CD. Reversal of reserpine-induced bradykinesia by a-methyldopa - new light on its modus operandi Brain Research. 71: 178-182. PMID 4821419 DOI: 10.1016/0006-8993(74)90204-2  1
1974 Duvoisin RC. Variations in the "on-off" phenomenon Advances in Neurology. 5: 339-340. PMID 4440582  1
1972 Duvoisin RC. Diphenidol for Levodopa Induced Nausea and Vomiting Jama: the Journal of the American Medical Association. 221: 1408. PMID 5068561 DOI: 10.1001/jama.1972.03200250048015  1
1972 Yahr MD, Duvoisin RC. Pyridoxine and Levodopa in The Treatment of Parkinsonism Jama: the Journal of the American Medical Association. 220: 861. PMID 5067358 DOI: 10.1001/jama.1972.03200060085023  1
1972 Duvoisin RC. Reserpine for tardive dyskinesia New England Journal of Medicine. 286: 611. PMID 5058810  1
1972 Duvoisin RC, Lobo-Antunes J, Yahr MD. Response of patients with postencephalitic Parkinsonism to levodopa Journal of Neurology Neurosurgery and Psychiatry. 35: 487-495. PMID 5049808  1
1972 Duvoisin RC. Part 2: The Cluster Headache Jama: the Journal of the American Medical Association. 222: 1403-1404. PMID 4678318 DOI: 10.1001/jama.1972.03210110043010  1
1972 Yahr MD, Duvoisin RC, Côté L, Cohen G. Pyridoxine, DOPA, and Parkinsonism Advances in Biochemical Psychopharmacology. 4: 185-194. PMID 4555927  1
1972 Yahr MD, Duvoisin RC. Drug therapy of parkinsonism New England Journal of Medicine. 287: 20-24. PMID 4555145  1
1971 Yahr MD, Duvoisin RC, Mendoza MR, Schear MJ, Barrett RE. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486) Transactions of the American Neurological Association. 96: 55-58. PMID 5159129  1
1971 Yahr MD, Duvoisin RC. Pyridoxine, Levodopa, and L-α-Methyldopa Hydrazine Regimen in Parkinsonism Jama: the Journal of the American Medical Association. 216: 2141. DOI: 10.1001/jama.1971.03180390051016  1
1970 Barrett RE, Yahr MD, Duvoisin RC. Torsion dystonia and spasmodic torticollis--results of treatment with L-dopa Neurology. 20: 107-113. PMID 5529472  1
1970 Duvoisin RC. Hypotension caused by L-dopa British Medical Journal. 3: 47. PMID 5427492  1
1970 Cote L, Yahr MD, Duvoisin RC, Wolf A, Marksbery W. Analysis of deaths in Parkinson patients on long-term levodopa therapy Transactions of the American Neurological Association. 95: 73-77. PMID 4998770  1
1969 Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM. Treatment of Parkinsonism With Levodopa Archives of Neurology. 21: 343-354. PMID 5820999 DOI: 10.1001/archneur.1969.00480160015001  1
1969 Duvoisin RC, Yahr MD, Coté LD. Pyridoxine reversal of L-dopa effects in Parkinsonism Transactions of the American Neurological Association. 94: 81-84. PMID 5374494  1
1968 Duvoisin RC, Katz R. Reversal of Central Anticholinergic Syndrome in Man by Physostigmine Jama: the Journal of the American Medical Association. 206: 1963-1965. PMID 5755090 DOI: 10.1001/jama.1968.03150090039008  1
1968 Pleasure DE, Lovelace RE, Duvoisin RC. The prognosis of acute polyradiculoneuritis Neurology. 18: 1143-1148. PMID 5750701 DOI: 10.1212/WNL.18.12.1143  1
1968 Yahr MD, Duvoisin RC. Medical therapy of Parkinsonism Modern Treatment. 5: 283-300. PMID 5655945  1
1968 Yahr MD, Duvoisin RC, Hoehn MM, Schear MJ, Barrett RE. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism Transactions of the American Neurological Association. 93: 56-63. PMID 4885744  1
1967 Duvoisin RC, Dettbarn WD. Cerebrospinal fluid acetylcholine in man Neurology. 17: 1077-1081. PMID 6069293  1
1967 Duvoisin RC. Cholinergic-Anticholinergic Antagonism in Parkinsonism Archives of Neurology. 17: 124-136. PMID 4382112 DOI: 10.1001/archneur.1967.00470260014002  1
1965 DUVOISIN RC. A REVIEW OF DRUG THERAPY IN PARKINSONISM Bulletin of the New York Academy of Medicine. 41: 898-910. PMID 14320529  1
1965 Duvoisin RC, Yahr MD. Posterior fossa aneurysms Neurology. 15: 231-241. PMID 14262321  1
1965 Duvoisin RC, Yahr MD. Encephalitis and Parkinsonism Archives of Neurology. 12: 227-239. PMID 14247380 DOI: 10.1001/archneur.1965.00460270003001  1
1965 Yahr MD, Duvoisin RC, Cowen D. Encephalopathy associated with carcinoma. Transactions of the American Neurological Association. 90: 80-6. PMID 5857782  1
1963 DUVOISIN RC, YAHR MD, SCHWEITZER MD, MERRITT HH. PARKINSONISM BEFORE AND SINCE THE EPIDEMIC OF ENCEPHALITIS LETHARGICA. Archives of Neurology. 9: 232-6. PMID 14049396 DOI: 10.1001/archneur.1963.00460090038003  1
1962 Duvoisin RC. Convulsive Syncope Induced by the Weber Maneuver Archives of Neurology. 7: 219-226. PMID 13888762 DOI: 10.1001/archneur.1962.04210030057008  1
1962 Duvoisin RC, Yahr MD. Compressive spinal cord and root syndromes in achondroplastic dwarfs Neurology. 12: 202-207. PMID 13888761  1
1961 Duvoisin RC. The valsalva maneuver in the study of syncope Electroencephalography and Clinical Neurophysiology. 13: 622-626. PMID 13888763  1
Show low-probability matches.